Skip to content
Boost Up Blog – Lifestyle
Author:
Onco-Innovations Limited
Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
June 9, 2026
Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
June 5, 2026
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
June 2, 2026
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
May 22, 2026
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
May 21, 2026
Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
May 20, 2026
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
May 5, 2026
Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
May 2, 2026
Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
April 28, 2026
Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies
April 23, 2026
←
Previous Page
1
2
3
Next Page
→